Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

cGMP-selective PDE inhibitors under study at Bayer

Oct. 18, 2002

Duloxetine in urinary stress incontinence

Oct. 17, 2002

Novel potassium channel openers under study at Abbott

Oct. 17, 2002

Novel agents for urinary incontinence covered by Boehringer Ingelheim patent

Oct. 15, 2002

Merck patent covers novel alpha1A-adrenoceptor antagonists and their use in BPH

Oct. 14, 2002

Dutasteride approved for launch as first dual-acting 5alpha-reductase inhibitor for BPH

Oct. 11, 2002

Novel small-molecule leads targeting the V2 vasopressin receptor

Oct. 11, 2002

Reduction of RCN incidence with fenoldopam mesilate after contrast angiography

Oct. 10, 2002

Keryx extends manufacturing and negotiating rights for KRX-101

Oct. 8, 2002

Positive clinical results for PT-141 in moderate to severe MED

Oct. 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.